AstraZeneca's Covid-19 vaccine to begin clinical trials in China this year


SHANGHAI (Reuters) - AstraZeneca Plc plans to start early and mid-stage clinical trials of its COVID-19 vaccine candidate in China this year, a senior executive said on Friday, as it prepares a global rollout of the vaccine.

The vaccine candidate is already in the final stage of clinical trials in other countries, and AstraZeneca and its partner on the project, the University of Oxford, expect data from the late-stage trials this year. If successful, they will file for emergency approvals in as many countries as possible at the same.....

This article is no longer available in our repository.

There could be multiple reasons for this.